Answers are grounded in this paper and cite their sources.
Pilot registry study finds Robuvit® improves muscle strength in healthy subjects, suggesting beneficial effects on sarcopenia.
In conclusion, this pilot registry study suggests that 'primary' (idiopathic) sarcopenia can be reduced in otherwise healthy subjects with supplementation of Robuvit®. Robuvit® increased hand strength, muscular vascularization, subjective vigor and reduced plasma oxidative stress and urinary excretion of 3-methylhistidine a marker of muscle loss after 3 months.
No takes yet. Share an insight, caveat, or question.
BELCARO et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: